Keywords:
acute asthma; eosinophils; phenotypes; sputum; viral infection
Abstract:
Background and objective: Airway eosinophilia is associated with an increased risk of asthma exacerbations; however, the impact on the severity of exacerbations is largely unknown. We describe the sputum inflammatory phenotype during asthma exacerbation and correlate it with severity and treatment response.
Methods: Patients presenting to hospital with an asthma exacerbation were recruited during a 12-month period and followed up after 4weeks. Induced sputum was collected at both visits. Patients underwent spirometry, arterial blood gas analysis, fractional exhaled nitric oxide analysis, white blood cell counts and a screening for common respiratory viruses and bacteria. An eosinophilic exacerbation (EE) was defined as having sputum eosinophils≥3% and a non-eosinophilic exacerbation <3% (NEE).
Results: A total of 47 patients were enrolled; 37 (79%) had successful sputum induction at baseline, of whom 43% had sputum eosinophils ≥3% (EE). Patients with EE had a significantly lower forced expiratory volume in 1s (FEV1 ) % predicted (70.8%, P=0.03) than patients with NEE (83.6%). Furthermore, EE patients were more likely to require supplemental oxygen during admission (63% vs 14%, P=0.002). The prevalence of respiratory viruses was the same in EE and NEE patients (44% vs 52%, P=0.60), as was bacterial infection (6% vs 14%, P=0.44). Fractional expiratory nitric oxide (FeNO) correlated with sputum %-eosinophils (ρ=0.57, P<0.001), and predicted airway eosinophilia with a sensitivity of 86% and a specificity of 70%.
Conclusion: Our findings suggest that eosinophilic asthma exacerbations may be clinically more severe than NEEs, supporting the identification of these higher risk patients for specific interventions.